OrthoNovis, Inc. Receives FDA 510(k) Clearance to Market Innovative Wrist Fracture System

PALM COAST, Fla., Feb. 25, 2025 /PRNewswire/ -- OrthoNovis, Inc is proud to announce that it has received U.S. Food and Drug Administration (FDA) clearance to market its innovative BPS Wrist Fracture System. www.orthonovis.com

“This milestone will allow OrthoNovis to compete in the rapidly growing US orthopedic fracture fixation market,” says Ken West, President, and CEO. “Our BPS Wrist Fracture System is a critical step in the build-out of our complete line of orthopedic implants featuring our patented technologies and financially responsible pricing. We are well positioned to grow and will be releasing several new product lines that will address the treatment and fixation of commonly performed Orthopaedic procedures.”

About OrthoNovis: OrthoNovis, Inc is a manufacturer and marketer of high quality, best in class Orthopaedic products sold at financially responsible prices. We seek to prove that superior products and lower costs can go hand in hand. OrthoNovis focuses on widely used, market proven products used to treat common fractures and bone osteotomies. The resulting products incorporate patented and clinically advanced features and are priced significantly less than the competition. OrthoNovis customers include ambulatory surgery centers, hospitals, and orthopedic surgeons. Please contact us at [email protected] for more information about our product and business model.

Sign up for Blog Updates